Back to search

Article

PTPRJ Drives Clonal Selection in CEBPA-mutated AML

2026-07-08

Abstract excerpt

Transcription factor CEBPA is mutated in 10-15% of acute myeloid leukaemia (AML), a haematopoietic malignancy with high mortality. CEBPA mutations show a distinct pattern, and most patients are biallelic, carrying both an in-frame C-terminal mutation and a frameshift N-terminal mutation on opposing alleles. Rare N-terminal germline cases have 100% penetrance to AML, all with an acquired a C-terminal mutation. Th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d0b61990-6252-50ec-bf20-65187ee07f26
DOI
10.64898/2026.07.07.736996
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PTPRJ Drives Clonal Selection in CEBPA-mutated AMLDOI 10.64898/2026.07.07.736996
Select a neighboring publication to make it the new centre.